Evidence map›Paper›PMID 41092154›Full record

ArticleEinstein (Sao Paulo, Brazil)2025

Judicial demands for prostate cancer treatment in Brazil: androgen receptor pathway inhibitors are an urgent public health problem.

Mariana Avelar da Silveira, Carla de Oliveira Ricomini, Reuli Cordeiro da Silva, Flavio Tocci Moreira, Carlos Henrique Sartorato Pedrotti, Vanessa Damazio Teich, Luciana Holtz de Camargo Barros, Sidney Glina, Fernando Korkes

Abstract read
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mariana Avelar da SilveiraHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0009-0003-7034-9515
Carla de Oliveira RicominiHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0009-0001-7555-2550
Reuli Cordeiro da SilvaCentro Universitário FMABC, Santo André, SP, Brazil.ORCID http://orcid.org/0009-0007-5809-0087
Flavio Tocci MoreiraHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0001-6574-3866
Carlos Henrique Sartorato PedrottiHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-0634-7086
Vanessa Damazio TeichHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-8539-6037
Luciana Holtz de Camargo BarrosInstituto Oncoguia, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-2184-044X
Sidney GlinaHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-9053-5046
Fernando KorkesHospital Israelita Albert Einstein, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0003-4261-4345

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 89% of the 3,136 legal demands sought medication. Androgen inhibitors amounted to 78.8% of all lawsuits, particularly abiraterone. There is a growth tendency in judicialization, with a 30-fold increase over 4 years. The estimated annual financial burden of judicialization on the Brazilian United Public Health System has reached BRL 783 million.

Indexed as

Androgen AntagonistsAndrogen Receptor AntagonistsProstatic NeoplasmsPublic HealthAndrostenesBrazilHumansMaleabirateroneAndrogen AntagonistsAndrogen Receptor AntagonistsAndrostenes

Identifiers

PMID41092154
PMCPMC12539861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.